Citius Aims To Use Prior Experience With CTCL Drug To Its Commercial Advantage

 
• By Alaric DeArment
Citius announced results of its Phase III trial of I/Ontak in cutaneous T-cell lymphoma • Source: Alamy

More from Rare Diseases

More from Scrip